Section 92a.50. CAAP

(a) Each discharger shall prepare and implement a BMP plan that addresses:

(1) Solids and excess feed management and removal.

(2) Proper facility operation and maintenance.

(3) Nonnative species loss prevention.

(4) Facility personnel training.

(5) Removal, handling and disposal/utilization of bio-residual solids (sludge).

(b) Permittees shall report any investigational/therapeutic drugs usage as follows:

(1) For investigational/new drugs, the permittee shall provide the Department with an oral notification within 7 days of initiating application of the drug, and a New Drug Usage Report shall be filed monthly.

(2) Changes in or increases in usage rates shall be reported to the Department through both oral notification and written report on the Drug Usage Report Form, quarterly.

(c) Products or chemicals that contain any carcinogenic ingredients are prohibited, except that limited use of those chemicals may be permitted provided that the permittee shall:

(1) Thoroughly investigate the use of alternative chemicals.

(2) Demonstrate that no suitable alternatives are available.

(3) Demonstrate through sampling or calculation that any carcinogen in the proposed chemical will not be detectable in the final effluent, using the EPA-approved analytic method for wastewater analysis with the lowest published detection limits.